Newcastle Disease Virus (NDV)-based vaccine candidate against SARS-CoV-2 Omicron by intranasal immunization.
Zhang QY, Zhang HQ, Zhang YN, Zhang ZR, Li XD, Hao MC, Zhang Y, Li JQ, Hu YY, Chen XL, Wang J, Shi YJ, Deng CL, Chen JJ, Ye HQ, Zhang B.
Zhang QY, et al. Among authors: ye hq.
Antiviral Res. 2023 Dec;220:105757. doi: 10.1016/j.antiviral.2023.105757. Epub 2023 Nov 19.
Antiviral Res. 2023.
PMID: 37984567